GLP-1s can be a life changing, and lifesaving, opportunity for members on your plan
This could lead to subtherapeutic thyroid hormone levels, manifesting as fatigue, weight gain (counteracting Wegovy's intended effect), cold intolerance, or other hypothyroid symptoms
Research shows that GLP-1 therapy influences insulin secretion, glucagon timing, and gut hormone patterns, creating broader metabolic changes that extend beyond weight reduction
These injections are administered once weekly by subcutaneous injection
This can lead to a higher ratio of oestrogen to progesterone, known as oestrogen dominance, which has been shown to have a negative effect on fertility and also increases risk of conditions such as endometriosis and PMS